This is the third indication for Reblozyl (luspatercept), which is already used to treat anaemia in patients with rare blood disorder beta thalassaemia and as a second-line therapy for MDS ...

MDS are a group of closely related blood cancers in which there is ineffective production of healthy red blood cells, white blood cells, and platelets. This can lead to anaemia and frequent or ...